Friday, 12 September 2025 | ||
---|---|---|
13:30 - 14:00 | Opening & Introduction | |
13:30 - 13:40 | Welcome Speech by Organizing Committee | Aysun Ünal / Mesrure Köseoğlu |
13:40 - 14:00 | Opening Keynote | Ivan Milanov |
14:00 - 15:10 | Session 1: Innovations in Parkinson’s Diagnosis and Early Therapeutic Strategies | |
Chairs: Ayşe Bora Tokçaer / Desislava Bogdanova | ||
14:00 - 14:20 | Parkinson’s Disease: Molecular Pathology, Clinical Implications and Recent Advances | Bülent Elibol |
14:20 - 14:40 | Can Parkinson’s Disease be Diagnosed with Biomarkers? Evidence and Expert Debate | Raif Çakmur |
14:40 - 15:00 | From dusk to dawn: How to manage nighttime motor symptoms and maintaining activities of daily living for young patients | Sonya Ivanova |
15:00 - 15:10 | Questions & Answers | |
15:10 - 15:40 | COFFEE BREAK | |
15:40 - 16:50 | Session 2: Advanced Interventions and Future Therapies in Parkinson’s Disease | |
Chairs: Haşmet Hanağası / Sonya Ivanova | ||
15:40 - 16:00 | Brave new world: What have we learned and where are we heading with infusion therapies? | Desislava Bogdanova |
16:00 - 16:20 | Deep Brain Stimulation and Neurosurgical Interventions in Parkinson’s Disease | Gençer Genç |
16:20 - 16:40 | Novel and Translational Therapeutics for Parkinson’s Disease | Okan Doğu |
16:40 - 16: 50 | Q & A | |
16:50 - 17:50 | Session 3: Interactive Discussion with Young Clinicians and Experts | |
Chairs: Bülent Elibol / Ivan Milanov / Serkan Özben | Panelists: | |
Expert Panel & Audience Dialogue: The Future of Parkinson’s Care | Haşmet Hanağası, Raif Çakmur, Sonya Ivanova, Desislava Bogdanova, Gençer Genç, Sami Ömer Hoca |
Saturday, 13 September 2025 | ||
---|---|---|
09:00 - 10:00 | Session 4: Innovations in Diagnosis and Emerging Therapies for Alzheimer’s Disease | |
Chairs: Esen Saka Topçuoğlu / Elka Stefanova | ||
09:00 - 09:20 | From Silence to Signs: Imaging Insights into Alzheimer’s Disease | Erdi Şahin |
09:20 - 09:40 | The role of fluid biomarkers in Alzheimer's disease diagnosis - report from the Memory Clinic | Elka Stefanova |
09:40 - 10:00 | Anti-Amyloid Immune Therapies in Alzheimer’s Disease: Are We on the Right Track? | Başar Bilgiç |
10:00 - 10:20 | COFFEE BREAK | |
10:20 - 11:10 | Session 5: Neurodegenerative Disorders: Behavioural Profiles and Treatment Approaches | |
Chairs: Başar Bilgiç / Shima Mehrabian | ||
10:20 - 10:40 | Cognitive and Behaviour Impairments in Neurodegenerative Disorders with Parkinsonism | Elka Stefanova |
10:40 - 11:00 | Pharmacological and Non-Pharmacological Approaches to Dementia: Insights from Bulgaria and Türkiye | Bulgaria: Latchezar Traykov Türkiye: Nazlı Durmaz Çelik |
11:00 - 11:10 | Q& A | |
11:10 - 12:10 | Session 6: Interactive Discussion with Young Clinicians and Experts | |
Chairs: Esen Saka Topçuoğlu / Latchezar Traykov / Aysun Ünal | Panelists: | |
Expert Panel & Audience Dialogue: Shaping the Next Decade in Alzheimer’s Disease | Başar Bilgiç, Erdi Şahin, Elka Stefanova, Shima Mehrabian, Nazlı Durmaz Çelik, Sami Ömer Hoca | |
12:10- 13:30 | LUNCH BREAK | |
13:30 - 14:40 | Session 7: Advances in Early Detection and Functional Assessment in Multiple Sclerosis | |
Chairs: Ayşe Altıntaş / Dimitar Maslarov | ||
13:30 - 13:50 | Diagnosing MS Before It clinically Surfaces: A New Era of Detecting Asymptomatic Disease | Aksel Siva |
13:50 - 14:10 | Neuroinflammation as a Driver of MS Progression | Dimitar Maslarov |
14:10 - 14:30 | Unveiling the Silent Progression of Multiple Sclerosis | Murat Kürtüncü |
14:30 - 14:40 | Q & A | |
14:40 - 15:00 | COFFEE BREAK | |
15:00 - 16:10 | Session 8: Therapeutic Frontiers in Multiple Sclerosis | |
Chairs: Murat Terzi / Sonya Ivanova | ||
15:00 - 15:20 | Should Every Sign of MS Activity Be Treated? Symptoms, Silent Lesions and Steroids | Yes: Melih Tütüncü No: Michaela Sergeeva |
15:20 - 15:40 | Preventing Progression in MS: Current and Emerging Treatment Strategies | Uğur Uygunoğlu |
15:40 - 16:00 | Can MS Therapy Be Discontinued? A Debate on Long-Term Treatment Strategies | Yes: Tuncay Gündüz No: Paulina Ilieva |
16:00 -16:10 | Q & A | |
16:10 - 16:30 | COFFEE BREAK | |
16:30 - 17:30 | Session 9: Multicenter Dialogue on MS - From Shared Clinical Experience to Joint Research | |
Chairs: Rana Karabudak / Ivan Milanov / Mesrure Köseoğlu | Panelists: | |
Panel & Audience Dialogue: Advancing Multicenter Approaches to MS Care, Policy, and Research. | Hüsnü Efendi, Aksel Siva, Dimitar Maslarov, Serkan Özben, Mehmet Fatih Yetkin, Mehmet Demir, Sami Ömer Hoca |
Sunday, 14 September 2025 | ||
---|---|---|
09:00 - 09:30 | Poster Sessions | Ufuk Emre Toprak / Ivan Milanov |
09:30 - 10:20 | Session 10: Immune Targets and Therapies in Neurological Disorders | |
Chairs: Sibel Canbaz Kabay / Sıla Usar İncirli | ||
09:30 - 09:50 | MOG & NMO Therapies: Aligning Evidence, Experience and Expectations | Ivan Milanov |
09:50 - 10:10 | Immune-Based Therapies in Neurology: The Expanding Role of IVIg in CNS Disorders | Mesude Tütüncü |
10:10 - 10:20 | Q & A | |
10:30 - 11:40 | Session 11: Beyond the Brain: Multisystem Approaches to Neurodegenerative Diseases | |
Chairs: Aslı Tuncer / Nilüfer Kale İçen / Cavit Boz | ||
10:30 - 10:45 | Hormonal Influences on Neuropathic Pain: The Endocrine-Neural Interface in Neurodegeneration | Meral Mert |
10:45 - 11:00 | Cardiovascular Risk and Neurodegeneration: Shared Mechanisms and Bidirectional Impact | Gönenç Kocabay |
11:00 - 11:15 | Cancer, Cellular Aging, and Neurodegeneration: An Oncologic Viewpoint | Galina Kurteva |
11:15 - 11:30 | Neurorehabilitation and Neuropathic Pain: A Multidisciplinary Challenge | Sibel Çağlar |
11:30 - 11:40 | Q & A | |
11:40 - 12:00 | Closing Remarks & Future Collaborations | Ivan Milanov |
Closing Speech by Organizing Committee | Serkan Özben |